Danya Garner, PhD, RN, NPD-BC, OCN®, CCRN-K, associate director of continuing professional education at The University of Texas MD Anderson Cancer Center in Houston, will serve as the next Oncology Nursing Society president. During its November 2022 meeting, the ONS Board of Directors appointed Garner to succeed Jeannine Brant, PhD, APRN-CNS, AOCN®, FAAN, who concludes her three-year board tenure at ONS’s 48th Annual Congress® in San Antonio, TX.

None of the patients who were admitted for an immune checkpoint inhibitor–related toxicity but received structured teaching at discharge were subsequently readmitted within 30 days, compared to nearly 50% of patients who did not receive teaching, ONS member Michelle L. Rohlfs, DNP, APRN, FNP-BC, AOCNP^®, reported in study findings published in the Clinical Journal of Oncology Nursing.

On February 9, 2023, the U.S. Food and Drug Administration approved dostarlimab-gxly (Jemperli®) for adult patients with mismatch repair deficient recurrent or advanced endometrial cancer, as determined by an FDA-approved test, that has progressed on or following a prior platinum-containing regimen in any setting and are not candidates for curative surgery or radiation.

Bringing together more than 3,000 oncology nurses and other cancer care providers, the Oncology Nursing Society hosts its 48th Annual ONS Congress in San Antonio, TX, from April 26–30, 2023. As the largest, most comprehensive oncology nursing conference in the United States, the annual event offers educational sessions, networking opportunities, and groundbreaking nursing research reports.

The National Institutes of Health, through its All of Us Research Program, announced in January 2023 research funding opportunities to expand the use of the program’s data to advance precision medicine. NIH allocated up to $4.75 million in fiscal year 2023 for the research grants.

The complexity of cancer care may affect patients’ financial toxicity more than we’ve realized. Many patients struggle with the economic burden of out-of-pocket spending for cancer care, including insurance copayments, transportation, and reduced income, as well as their psychological burden of worry and coping with less funds for food and medications.

Continuing the fight toward health equity, the Centers for Medicare and Medicaid Services’ Office of Minority Health released a report in November 2022 on current progress and future actions to improve health equity data collection.

Anger is a common emotion for both patients and their partners when facing cancer, but in almost a quarter of relationships, that anger turns psychologically or physically violent. According to the results of a new study published in Supportive Care in Cancer, both genders report acts of abuse from their partners during the cancer journey.

On February 2, 2023, the U.S. Food and Drug Administration reported Smiths Medical’s recall of its CADD™ infusion system administration sets and cassette reservoirs because of tubing occlusions that may under- or not deliver medication and false no disposable attached alarms that may prevent pump use. FDA identified it as a class I recall, the most serious type of recall, where use may cause serious injuries or death.

As a clinician in inpatient cardiovascular and acute care nursing and as a healthcare administrator, like many of my colleagues across the nation, I have encountered many violent situations in the workplace. Healthcare workers account for 73% of all violence-related nonfatal workplace injuries and illnesses, and nurses bear the brunt of that statistic, with 44% reporting physical violence and 68% reporting verbal. In fact, in 2022, more than two nurses were assaulted every hour. The rate of violence-related injuries is higher in health care than in all other occupational settings.